Lupin receives USFDA approval for Chlorpromazine Hydrochloride tablets
This product will be manufactured at Lupin’s Somerset facility in the U.S.
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
USFDA
Lupin gets tentative US FDA approval for Dolutegravir Tablets for Oral Suspension
This product will be manufactured at Lupin’s Nagpur facility in India
Lupin gets US FDA approval for Tiotropium dry powder inhaler
This product will be manufactured at Lupin’s Pithampur facility in India
USFDA completes GMP inspection of Dr Reddy’s Hyderabad API manufacturing facility
The inspection closed with zero observations
USFDA concludes inspection at Zydus’ Ahmedabad facility
The cGMP inspection concluded with nil observations
Caplin Steriles gets USFDA nod for Cisatracurium Besylate injection
Cisatracurium Besylate Injection USP is a nondepolarising skeletal neuromuscular blocker, indicated as an adjunct to general…
Zydus announces Phase IV EVIDENCES-XI trial to generate RWE of Saroglitazar Mg in NAFLD patients…
Phase IV EVIDENCES- XI trial will enroll approximately 1500 NAFLD patients with comorbidities
Exploring synergies and de-risking strategies
Even as pharma companies continue the long-term process of reducing dependence on outside sources for key input materials,…
For pharma cos, formulation exports to rise 7-9 per cent this fiscal
Revival in US sales, sustained healthy performance in rest of the world to drive growth
Rakuten Medical to start phase 3 trial of Alluminox treatment using ASP-1929 for head and neck…
This ASP-1929-301 study is currently underway in several countries such as the US and Taiwan, and will enroll 275 patients…